{
    "nctId": "NCT03102307",
    "briefTitle": "Registry Trial to Evaluate the Clinical Utilization of Targeted Axillary Dissection (TAD)",
    "officialTitle": "A Prospective, Multicenter, Registry Trial to Evaluate Utilization Frequency and Feasibility of Targeted Axillary Dissection (TAD) After Needle Biopsy and Clip Placement in Early Breast Cancer With Clinically Affected Lymph Nodes",
    "overallStatus": "COMPLETED",
    "conditions": "Early Stage Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 548,
    "primaryOutcomeMeasure": "Surgical detection rate of the clip labeled target lymph node",
    "eligibilityCriteria": "Inclusion Criteria\n\n* informed consent\n* invasive mamma carcinoma verified by needle biopsy of the primary tumor\n* nodal positive (cN+) verified by axillary ultrasound\n* cT stage 1-4c, multifocality allowed\n* no sign of distant metastasis (cM0)\n\nExclusion Criteria:\n\n* prior history of breast cancer\n* prior ipsilateral extensive surgery of breast or axilla\n* inflammatory or extramammary breast cancer\n* pregnancy\n* inability to understand the studies purpose\n* no written patient informed consent",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}